Anti-MCV: Advancing RA Diagnosis with New Citrullinated Proteins

Thursday, August 1
Time: 10:15 a.m. - 11:15 a.m.
Location: Exhibit Hall Theater 1
Sponsored by Sebia


Traditional tests for rheumatoid arthritis (RA) detect the autoantibodies rheumatoid factor and anti-cyclic citrullinated peptide (CCP). But neither test identifies all patients with the disorder, especially in the early stages when intervention can prevent more serious disease later. This session will discuss the role of citrullination in RA, the evolution of anti-CCP assays, and the search for antibodies to individual citrullinated proteins which may be used to complement anti-CCP in the diagnosis and management of RA. The utility of antibodies to the mutated version of citrullinated vimentin will be highlighted.


Oliver Sendscheid, PhD
Autoimmunity Business Area Director, Sebia


James D. Faix, MD
Medical Director, Immunology, Quest Diagnostics Nichols Institute

Holger Bang, PhD
Scientific Director, Orgentec by Sebia